There's no major story in U.S. pharma stocks today. Johnson & Johnson barely moved, Moderna fell over two percentage points, with vaccine demand remaining sluggish and dragging on. Brainstorm Cell Therapeutics rose slightly, and small-cap biotechs have their own rhythm. Big pharma seeks stability within the expectations of medical insurance negotiations, while small caps fluctuate based on their respective clinical progress. Overall, everyone is waiting for a catalyst.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
